| Date | Time | Source | Headline | Symbol | Company |
| 08/30/2023 | 7:00AM | InvestorsHub NewsWire | Medicure reiterates its commitment to providing exceptional access to its branded pitavastatin (zypitamag) to people living with hiv | TSXV:MPH | Medicure Inc |
| 02/01/2023 | 7:00AM | PR Newswire (Canada) | MEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONS | TSXV:MPH | Medicure Inc |
| 11/24/2022 | 5:00PM | PR Newswire (Canada) | MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022 | TSXV:MPH | Medicure Inc |
| 11/17/2022 | 5:00PM | PR Newswire (Canada) | MEDICURE TO PRESENT FINANCIAL RESULTS ON NOVEMBER 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED SEPTEMBER 30, 2022 | TSXV:MPH | Medicure Inc |
| 09/26/2022 | 9:00AM | PR Newswire (Canada) | EARLY WARNING NEWS RELEASE - DR. ALBERT D. FRIESEN'S HOLDINGS IN MEDICURE INC. | TSXV:MPH | Medicure Inc |
| 08/24/2022 | 5:00PM | PR Newswire (Canada) | MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED JUNE 30, 2022 | TSXV:MPH | Medicure Inc |
| 08/17/2022 | 5:00PM | PR Newswire (Canada) | MEDICURE TO PRESENT FINANCIAL RESULTS ON AUGUST 25, 2022 CALL at 8:30 AM ET FOR QUARTER ENDED JUNE 30, 2022 | TSXV:MPH | Medicure Inc |
| 06/20/2022 | 5:00PM | PR Newswire (Canada) | MEDICURE ANNOUNCES RESULTS OF 2022 AGM | TSXV:MPH | Medicure Inc |
| 05/30/2022 | 7:00PM | PR Newswire (Canada) | MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED MARCH 31, 2022 AND APPOINTMENT OF HAARIS UDDIN AS CHIEF FINANCIAL OFFICER | TSXV:MPH | Medicure Inc |
| 04/27/2022 | 8:00PM | PR Newswire (Canada) | MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER AND YEAR ENDED DECEMBER 31, 2021 | TSXV:MPH | Medicure Inc |
| 04/26/2022 | 1:00PM | PR Newswire (Canada) | MEDICURE TO REPORT FINANCIAL RESULTS FOR YEAR ENDED DECEMBER 31, 2021 ON APRIL 28TH AT 7:30 AM CST | TSXV:MPH | Medicure Inc |
| 03/23/2022 | 5:00PM | PR Newswire (Canada) | MEDICURE ANNOUNCES RESIGNATION OF CHIEF FINANCIAL OFFICER AND SUCCESSION PLAN | TSXV:MPH | Medicure Inc |
| 02/22/2022 | 9:00AM | PR Newswire (Canada) | Medicure's Subsidiary - Marley Drug to Partner with RxSpark, the Next Generation in Pharmacy Discount Programs, to be its Sole Mail-Order Pharmacy | TSXV:MPH | Medicure Inc |
| 02/09/2022 | 9:53AM | PR Newswire (Canada) | Medicure Launches E-Commerce Pharmacy Platform - www.marleydrug.com Through its Subsidiary Marley Drug Pharmacy | TSXV:MPH | Medicure Inc |
| 11/22/2021 | 5:00PM | PR Newswire (Canada) | Medicure Reports Financial Results for Quarter Ended September 30, 2021 | TSXV:MPH | Medicure Inc |
| 11/22/2021 | 9:00AM | PR Newswire (Canada) | Medicure Plans To Launch Innovative E-Commerce Pharmacy Platform Offering Hundreds of Medications Directly To Millions of Americans | TSXV:MPH | Medicure Inc |
| 11/04/2021 | 5:00PM | PR Newswire (Canada) | Medicure Announces that the Shortened AGGRASTAT® Versus INTEGRILIN® in Percutaneous Coronary Intervention (SAVI-PCI) Study has Met its Primary Endpoint | TSXV:MPH | Medicure Inc |
| 08/27/2021 | 5:00PM | PR Newswire (Canada) | Medicure Reports Financial Results for the Second Quarter Ended June 30, 2021 | TSXV:MPH | Medicure Inc |
| 07/30/2021 | 8:00AM | PR Newswire (Canada) | Medicure Announces Grant of Stock Options | TSXV:MPH | Medicure Inc |
| 06/24/2021 | 5:01PM | PR Newswire (Canada) | Medicure Announces Appointment of David Gurvey as Chief Financial Officer | TSXV:MPH | Medicure Inc |
| 05/10/2021 | 5:30PM | PR Newswire (Canada) | Medicure Reports Financial Results for Quarter Ended March 31, 2021 | TSXV:MPH | Medicure Inc |
| 05/05/2021 | 3:03PM | PR Newswire (Canada) | Medicure 2020 Annual and Q1 2021 Results and Conference Call Date | TSXV:MPH | Medicure Inc |
| 04/28/2021 | 5:01PM | PR Newswire (Canada) | Medicure Announces Resignation of Chief Financial Officer and Succession Plan | TSXV:MPH | Medicure Inc |
| 04/20/2021 | 6:00PM | PR Newswire (Canada) | Medicure Reports Financial Results for Quarter and Year Ended December 31, 2020 | TSXV:MPH | Medicure Inc |
| 03/29/2021 | 7:26PM | PR Newswire (Canada) | Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 30, 2021 | TSXV:MPH | Medicure Inc |
| 03/08/2021 | 5:30PM | PR Newswire (Canada) | Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 9, 2021 | TSXV:MPH | Medicure Inc |
| 02/22/2021 | 6:17PM | PR Newswire (Canada) | Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, February 23, 2021 | TSXV:MPH | Medicure Inc |
| 02/04/2021 | 5:30PM | PR Newswire (Canada) | Medicure To Participate In Renmark's Virtual Non-Deal Roadshow Series on Monday, February 8, 2021 | TSXV:MPH | Medicure Inc |
| 01/27/2021 | 5:30PM | PR Newswire (Canada) | Medicure Announces Early Completion of Enrollment for iSPASM, a Phase 1/2a Exploratory Clinical Trial of AGGRASTAT® (tirofib... | TSXV:MPH | Medicure Inc |
| 01/07/2021 | 5:30PM | PR Newswire (Canada) | Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment of Seizures Associated with Pyridox(am)ine 5'-phos... | TSXV:MPH | Medicure Inc |